Ella H Sklan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Duchenne Muscular Dystrophy

Advanced Non Small Cell Lung Cancer

Estrogen Receptor

Top Venues

Science advances

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yehonathan Malis, Shir Armoza-Eilat, Inbar Nevo-Yassaf, Anna Dukhovny, Ella H Sklan, Koret Hirschberg
Rab1b facilitates lipid droplet growth by ER-to-lipid droplet targeting of DGAT2. Science advances 10 (22) (2024)
Yehonathan Malis, Shir Armoza-Eilat, Inbar Nevo-Yassaf, Anna Dukhovny, Ella H Sklan, Koret Hirschberg
Rab1b facilitates lipid droplet growth by ER-to-lipid droplet targeting of DGAT2. Science advances 10 (22) (2024)
Yehonathan Malis, Shir Armoza-Eilat, Inbar Nevo-Yassaf, Anna Dukhovny, Ella H Sklan, Koret Hirschberg
Rab1b facilitates lipid droplet growth by ER-to-lipid droplet targeting of DGAT2. Science advances 10 (22) (2024)
Ron Fisher, Yaniv Lustig, Ella H Sklan, Eli Schwartz
The Role of NS1 Protein in the Diagnosis of Flavivirus Infections. Viruses 15 (2) (2023)
Ron Fisher, Yaniv Lustig, Ella H Sklan, Eli Schwartz
The Role of NS1 Protein in the Diagnosis of Flavivirus Infections. Viruses 15 (2) (2023)
Ron Fisher, Yaniv Lustig, Ella H Sklan, Eli Schwartz
The Role of NS1 Protein in the Diagnosis of Flavivirus Infections. Viruses 15 (2) (2023)
Ronen Siman-Tov, Rulla Shalabi, Amir Shlomai, Elad Goldberg, Wesam Essa, Eden Shusterman, Jacob N Ablin, Michal Caspi, Rina Rosin-Arbesfeld, Ella H Sklan
Elevated Serum Amyloid A Levels Contribute to Increased Platelet Adhesion in COVID-19 Patients. International journal of molecular sciences 23 (22) (2022)
Summer Sofer, Kevin Lamkiewicz, Shir Armoza Eilat, Shirly Partouche, Manja Marz, Neta Moskovits, Salomon M Stemmer, Amir Shlomai, Ella H Sklan
A genome-wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (3) (2022)